Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FABP1 | P07148 | 2/20 | 0.46 |
| ▸ | KCNA5 | P22460 | 1/20 | 0.44 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.44 |
| ▸ | NTSR1 | P30989 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | MEN1 | O00255 | 3/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.43 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | PKLR | P30613 | 3/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7686601 | 0.91 | TRPV1 (0.46) | FABP1KCNA5TRPV1NTSR1ALDH1A1 | |
| SCHEMBL7388646 | 0.88 | MEN1 (0.49) | FABP1KCNA5TRPV1NTSR1ALDH1A1 | |
| SCHEMBL7690188 | 0.87 | EGFR (0.48) | MEN1KMT2AMAPT | |
| SCHEMBL7680584 | 0.84 | AKR1C3 (0.48) | ALDH1A1MEN1KMT2AGAA | |
| SCHEMBL7686060 | 0.82 | EGFR (0.46) | MEN1KMT2AMAPT | |
| SCHEMBL7689333 | 0.79 | OPRM1 (0.47) | MEN1KMT2AMAPT | |
| SCHEMBL7661487 | 0.79 | EGFR (0.47) | MEN1KMT2A | |
| SCHEMBL7564537 | 0.79 | CA2 (0.54) | ALDH1A1TSHRGAANPSR1 | |
| SCHEMBL7665441 | 0.78 | EGFR (0.46) | MEN1KMT2A | |
| SCHEMBL7789833 | 0.77 | ALDH1A1 (0.50) | FABP1KCNA5TRPV1NTSR1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6436925-B1 | BETTER ABLE TO CROSS MEMBRANES; INHIBITORS OF CYSTEINE PROTEASES LIKE CALPAIN I AND II AND CATHEPSIN B AND L, CAN THUS BE USED TO CONTROL DISEASES ASSOCIATED WITH AN ELEVATED ACTIVITY OF CALPAIN ENZYMES OR CATHEPSIN ENZYMES | ABBOTT LABORATORIES | 2002-08-20 | — | — | US | disclosed |